cyanidin has been researched along with gallic acid in 4 studies
| Studies (cyanidin) | Trials (cyanidin) | Recent Studies (post-2010) (cyanidin) | Studies (gallic acid) | Trials (gallic acid) | Recent Studies (post-2010) (gallic acid) |
|---|---|---|---|---|---|
| 388 | 1 | 289 | 4,793 | 42 | 2,579 |
| Protein | Taxonomy | cyanidin (IC50) | gallic acid (IC50) |
|---|---|---|---|
| Urokinase-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Tissue-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Plasminogen activator inhibitor 1 | Homo sapiens (human) | 6.6 | |
| Urokinase-type plasminogen activator | Mus musculus (house mouse) | 6.6 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 4.03 | |
| Matrilysin | Homo sapiens (human) | 4.03 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 4.65 | |
| Alpha-synuclein | Homo sapiens (human) | 4.43 | |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | 4.03 | |
| Polypeptide N-acetylgalactosaminyltransferase 2 | Homo sapiens (human) | 1.37 | |
| Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | 4.03 | |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | 4.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bijak, M; Krotkiewski, H; Nowak, P; Pawlaczyk, I; Ponczek, M; Saluk, J; Wachowicz, B; Ziewiecki, R | 1 |
| Bordignon-Luiz, MT; Corrêa, LC; da Conceição Prudêncio Dutra, M; de Oliveira, D; Lima, Mdos S; Ninow, JL; Pereira, GE; Toaldo, IM | 1 |
| Del Bo', C; Loft, S; Møller, P; Porrini, M; Riso, P; Roursgaard, M | 1 |
| Bonnländer, B; Lang, S; Micka, A; Schön, C; Steudle, J; Wacker, R | 1 |
4 other study(ies) available for cyanidin and gallic acid
| Article | Year |
|---|---|
Thrombin inhibitory activity of some polyphenolic compounds.
Topics: | 2014 |
Phenolic compounds, organic acids and antioxidant activity of grape juices produced in industrial scale by different processes of maceration.
Topics: Anthocyanins; Antioxidants; Biflavonoids; Caffeic Acids; Catechin; Cinnamates; Food Handling; Fruit and Vegetable Juices; Gallic Acid; Phenols; Polygalacturonase; Principal Component Analysis; Proanthocyanidins; Resveratrol; Stilbenes; Temperature; Vitis | 2015 |
Different effects of anthocyanins and phenolic acids from wild blueberry (Vaccinium angustifolium) on monocytes adhesion to endothelial cells in a TNF-α stimulated proinflammatory environment.
Topics: Anthocyanins; Atherosclerosis; Blueberry Plants; Cell Adhesion; E-Selectin; Endothelium, Vascular; Gallic Acid; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Hydroxybenzoates; Intercellular Adhesion Molecule-1; Monocytes; NF-kappa B; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2016 |
Bioavailability Study of Maqui Berry Extract in Healthy Subjects.
Topics: Adult; Anthocyanins; Biological Availability; Dietary Supplements; Female; Fruit; Gallic Acid; Glucosides; Healthy Volunteers; Humans; Hydroxybenzoates; Magnoliopsida; Male; Plant Extracts; Young Adult | 2018 |